Skip to content

Building Collaborations to Address Drug Problems in the United States and China

CompletedNot applicableNCT04021030
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the impact of a Cognitive Behavioral Therapy (CBT) intervention on the distribution and variability of pain level before and after intervention receipt among people with co-occurring chronic pain and Substance Use Disorders (SUDs) over a three-month follow-up period.

Study details

Official title
Building Collaborations to Address Drug Problems in the United States and China
Conditions
Sponsor
University of Michigan
Collaborators
Michigan Medicine - PKUHSC Joint Institute for Translational and Clinical Research; Peking University; Meridian Health Services
Start date
2019-10-04
Primary completion
2021-01-06
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * At least 18 years of age * Currently receiving detoxification treatment * Report pain of at least moderate or greater intensity over the three months prior to baseline assessment as indicated by an average score of four or greater on the Numeric Rating Scale (NRS) * Have access to a phone for confidential personal therapy after the completion of detoxification treatment. For individuals who enter the residential treatment at the facility following the detoxification treatment, a research therapist will meet with them in person at a private office at the facility during their stay due to program's restriction on phone usage. Exclusion Criteria: * Inability to speak and understand English * Inability to give informed, voluntary, written consent

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04021030